Theseus Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Theseus Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q3 2023.
  • Theseus Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was -0.31 USD/shares, a 18.4% increase year-over-year.
  • Theseus Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -1.35 USD/shares, a 110% decline year-over-year.
  • Theseus Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.31 USD/shares, a 53.9% increase from 2021.
  • Theseus Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -2.84 USD/shares, a 86.5% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1 $0 +$0.07 +18.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 -$1 $0 $0 -13.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$1 $0 $0 -25.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$1 $0 -$14 -103% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-09
Q3 2022 $13.10 $0 +$4.78 +92.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 $8.31 $0 +$6.52 +95.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.79 $0 +$4.63 +94.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$3 $14.00 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$5 -$3 -143% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$7 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$5 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$2 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.